Doctors: Too Few Cancer Patients Enroll in Studies
In an article published on January 28th, Marilynn Marchione, Associated Press Chief Medical Writer, explores the issue of enrollment in clinical trials and the impact of patient enrollment in testing new treatments. The article cites the recent analysis of thousands of experiments registered on clinicaltrials.gov lead by Dr. Matthew Galsky of the Icahn School of Medicine at Mount Sinai Hospital in New York. NCCS CEO Shelley Fuld Nasso offered a perspective of one of the barriers to patients enrolling in clinical trials.
“Patients still have concerns about getting a placebo, but they’re always going to get at a minimum the standard of care. Doctors need to encourage more patients to participate, and clinical trial designers need to make sure they are testing key questions and treatments to honor the contributions of study participants.”